Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Downar

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
The American Journal of Psychiatry|February 4, 2020
Caution When Continuing Benzodiazepines During rTMS: Response to Hunter and LeuchterTyler S Kaster, Jonathan Downar, Fidel Vila-Rodriguez, et al.
Journal of Clinical Psychopharmacology|May 18, 2017
Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case SeriesMaryam I Al Shirawi, Sidney H Kennedy, Keith T Ho, et al.
Biological Psychiatry|August 22, 2018
A Case for the Frontal Pole as an Empirically Derived Neuromodulation Treatment TargetColleen A Hanlon, Noah S Philip, Rebecca B Price, et al.
Brain Stimulation|July 28, 2019
Impact of prior treatment on remission with intermittent theta burst versus high-frequency repetitive transcranial magnetic stimulation in treatment resistant depressionJonathan H Hsu, Jonathan Downar, Fidel Vila-Rodriguez, et al.
Brain Stimulation|October 16, 2020
Predicting treatment response to 1Hz rTMS using early self-rated clinical changes in major depressionMarine Mondino, David Szekely, Maxime Bubrovszky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 21, 2017
1Hz rTMS of the right orbitofrontal cortex for major depression: Safety, tolerability and clinical outcomesKfir Feffer, Peter Fettes, Peter Giacobbe, et al.
Brain Stimulation|July 12, 2025
Trigeminal nerve stimulation as an active control condition in TMS clinical trials: Evidence from heart-brain coupling and clinical outcomesMartijn Arns, Nolan R Williams, Jonathan Downar, et al.
Lancet (London, England)|February 5, 2019
Repetitive transcranial magnetic stimulation for depression - Authors' replyDaniel M Blumberger, Fidel Vila-Rodriguez, Kevin E Thorpe, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 31, 2013
Neuromodulation for treatment-refractory major depressive disorderNir Lipsman, Tejas Sankar, Jonathan Downar, et al.
Neuromodulation : Journal of the International Neuromodulation Society|November 10, 2018
A Comprehensive Review of Dorsomedial Prefrontal Cortex rTMS Utilizing a Double Cone CoilPeter M Kreuzer, Jonathan Downar, Dirk de Ridder, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
The American Journal of Psychiatry|February 4, 2020
Caution When Continuing Benzodiazepines During rTMS: Response to Hunter and LeuchterTyler S Kaster, Jonathan Downar, Fidel Vila-Rodriguez, et al.
Journal of Clinical Psychopharmacology|May 18, 2017
Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case SeriesMaryam I Al Shirawi, Sidney H Kennedy, Keith T Ho, et al.
Biological Psychiatry|August 22, 2018
A Case for the Frontal Pole as an Empirically Derived Neuromodulation Treatment TargetColleen A Hanlon, Noah S Philip, Rebecca B Price, et al.
Brain Stimulation|July 28, 2019
Impact of prior treatment on remission with intermittent theta burst versus high-frequency repetitive transcranial magnetic stimulation in treatment resistant depressionJonathan H Hsu, Jonathan Downar, Fidel Vila-Rodriguez, et al.
Brain Stimulation|October 16, 2020
Predicting treatment response to 1Hz rTMS using early self-rated clinical changes in major depressionMarine Mondino, David Szekely, Maxime Bubrovszky, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 21, 2017
1Hz rTMS of the right orbitofrontal cortex for major depression: Safety, tolerability and clinical outcomesKfir Feffer, Peter Fettes, Peter Giacobbe, et al.
Brain Stimulation|July 12, 2025
Trigeminal nerve stimulation as an active control condition in TMS clinical trials: Evidence from heart-brain coupling and clinical outcomesMartijn Arns, Nolan R Williams, Jonathan Downar, et al.
Lancet (London, England)|February 5, 2019
Repetitive transcranial magnetic stimulation for depression - Authors' replyDaniel M Blumberger, Fidel Vila-Rodriguez, Kevin E Thorpe, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 31, 2013
Neuromodulation for treatment-refractory major depressive disorderNir Lipsman, Tejas Sankar, Jonathan Downar, et al.
Neuromodulation : Journal of the International Neuromodulation Society|November 10, 2018
A Comprehensive Review of Dorsomedial Prefrontal Cortex rTMS Utilizing a Double Cone CoilPeter M Kreuzer, Jonathan Downar, Dirk de Ridder, et al.
Pageof 20